Stephen Hecht
University of Minnesota · Department of Laboratory Medicine and Pathology, University of Minnesota
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
4
all conditions, ClinicalTrials.gov
NIH grants tied to them
20
11 more share only the name and are not shown
Trial papers
58
PubMed author-name match
Trials
Studies that name Stephen Hecht as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:56 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07134426 · Vaped PhenanthreneUniversity of Minnesota · recruiting · Former Smoker, Non-Smoker · principal investigator
- N/ANCT06983392 · Persistence of Oral DNA Adducts in Smokers and VapersUniversity of Minnesota · withdrawn · Smokers, Vaping, Healthy Volunteers · principal investigator
- Ph2NCT03978117 · Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and CarcinogensMasonic Cancer Center, University of Minnesota · completed · Healthy · principal investigator
- N/ANCT03284632 · e-Cigarette - DNA AdductsUniversity of Minnesota · completed · Smoking, Cigarette Smoking, Electronic Cigarettes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 11 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Mechanisms Underlying Population Differences in Lung Cancer Due to Cigarette SmokingP01CA138338 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2010 to 2026 · $2,058,139 awarded in 2026Same name and institution; not confirmed by an ID
- Metabolism of Carcinogenic Tobacco-Specific NitrosaminesR01CA081301 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 1999 to 2026 · $555,020 awarded in 2026Same name and institution; not confirmed by an ID
- High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neckR01CA263084 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2021 to 2025 · $555,005 awarded in 2025Same name and institution; not confirmed by an ID
- Targeted Analysis ResourceU2CES026533 · NIEHS · UNIVERSITY OF MINNESOTA · fiscal years 2015 to 2023 · $1,139,622 awarded in 2023Same name and institution; not confirmed by an ID
- Clinical Trial of Watercress in Detoxification of Environmental Toxicants and CarcinogensR01CA222005 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2018 to 2022 · $613,074 awarded in 2022Same name and institution; not confirmed by an ID
- e-Cigarettes: Formaldehyde DNA Adducts, Oxidative Damage, and Potential Toxicity and CarcinogenesisR01CA203851 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2017 to 2021 · $455,472 awarded in 2021Same name and institution; not confirmed by an ID
- Benzo[a]pyrene metabolism: phenotyping and genotypingR01CA092025 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2001 to 2016 · $298,238 awarded in 2016Same name and institution; not confirmed by an ID
- Tobacco Constituent and Biomarker Assessment CoreU19CA157345 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2012 to 2015 · $464,627 awarded in 2015Same name and institution; not confirmed by an ID
- Carcinogenesis & ChemopreventionP30CA077598 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 1998 to 2013 · $71,555 awarded in 2013Same name and institution; not confirmed by an ID
- Metabolism of Carcinogenic Tobacco-Specific NitrosaminesR37CA081301 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2004 to 2013 · $469,017 awarded in 2013Same name and institution; not confirmed by an ID
- DNA Adducts of the Carcinogen AcetaldehydeR01ES011297 · NIEHS · UNIVERSITY OF MINNESOTA · fiscal years 2002 to 2011 · $308,499 awarded in 2011Same name and institution; not confirmed by an ID
- Carcinogenic Cyclic Nitrosamine DNA AdductsR01CA085702 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2000 to 2010 · $320,088 awarded in 2010Same name and institution; not confirmed by an ID
- DETERMINING AND COMPARING THE PHARMACOKINETICS OF [D10]PHE IN SMOKERS AFTER ORALM01RR000400 · NCRR · UNIVERSITY OF MINNESOTA · fiscal years 2009 · $8,782 awarded in 2009Same name and institution; not confirmed by an ID
- Core B: Biomarkers CoreP50DA013333 · NIDA · UNIVERSITY OF MINNESOTA · fiscal years 1999 to 2008 · $467,564 awarded in 2008Same name and institution; not confirmed by an ID
- Lung Cancer Chemoprevention: Isothiocyanates, inositolR01CA102502 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2004 to 2008 · $283,302 awarded in 2008Same name and institution; not confirmed by an ID
- Tobacco CarcinogenesisR13CA117411 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 2005 · $5,000 awarded in 2005Same name and institution; not confirmed by an ID
- CHEMOPREVENTION OF LUNG AND ESOPHAGEAL CANCERP01CA046535 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 1998 to 2002 · $858,578 awarded in 2002Same name and institution; not confirmed by an ID
- METABOLIC ACTIVATION OF CARCINOGENSR35CA044377 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 1987 to 2000 · $349,052 awarded in 2000Same name and institution; not confirmed by an ID
- DIVISION OF CHEMICAL TOXICOLOGY SYMPOSIUMR13ES008848 · NIEHS · UNIVERSITY OF MINNESOTA · fiscal years 1996 · $13,000 awarded in 1996Same name and institution; not confirmed by an ID
- ISOTHIOCYANATES AND NITROSAMINE CARCINOGENESISU01CA046535 · NCI · UNIVERSITY OF MINNESOTA · fiscal years 1987 to 1996 · $972,771 awarded in 1996Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:56 UTC. The ranking covers the 200 most relevant of 58 PubMed records, and a shared surname and initials can bring in a namesake. All 58 on PubMed
- Randomized Trial of Reduced-Nicotine Standards for Cigarettes.N Engl J Med · 2015342 citationsRCR 16.2
- Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China.Cancer Epidemiol Biomarkers Prev · 2005242 citationsRCR 6.1
- Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.Addiction · 2010208 citationsRCR 7.6
- Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China.Cancer Prev Res (Phila) · 2014151 citationsRCR 5.4
- 144 citationsRCR 8.1
- Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China.Carcinogenesis · 2012102 citationsRCR 3.4
- Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.J Natl Cancer Inst · 200495 citationsRCR 3.3
- Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.J Natl Cancer Inst · 200484 citationsRCR 2.9
- Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.Cancer Epidemiol Biomarkers Prev · 200782 citationsRCR 2.8
- Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers.Cancer Prev Res (Phila) · 201676 citationsRCR 3.0